Nevertheless, diagnostic products are an important constituent of the market. After reviewing federal regulations, the report analyzes the markets for chemical anticancer drugs, biological products, and radiation therapy. Then, diagnostic products are described. The leading companies are profiled in a separate chapter. Values of the market in this report are for the year given, represent sales by companies in the marketplace, and are for the United States only.
Projections are in terms of real dollars and represent real growth.
Competition from other drugs or diagnostics plays a role in the success or failure of these agents. The values are generally based on the best estimates of those involved in the commercialization of the techniques. Products that are not of therapeutic benefit to the patient, such as pain relievers and artificial limbs, are not included in the market analysis. Accordingly, costs due to surgery, including the technique of bone marrow transplantation, are not considered in this report. Many believe that the manipulation of genetic information holds the key to products that will diagnose, treat, and prevent cancer.